Alpha Tau Medical Ltd.
DRTS
$7.10
-$0.22-3.01%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | 10.40% | 20.48% | 11.74% | -5.99% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 22.66% | 6.56% | 3.33% | -7.11% | |
| Operating Income | -22.66% | -6.56% | -3.33% | 7.11% | |
| Income Before Tax | -28.47% | -36.42% | -28.78% | -39.85% | |
| Income Tax Expenses | -1,850.00% | 2,066.67% | -75.00% | 100.00% | |
| Earnings from Continuing Operations | -28.07% | -37.25% | -28.66% | -40.96% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -28.07% | -37.25% | -28.66% | -40.96% | |
| EBIT | -22.66% | -6.56% | -3.33% | 7.11% | |
| EBITDA | -22.96% | -6.92% | -3.35% | 7.59% | |
| EPS Basic | -4.29% | -19.15% | -27.57% | -39.69% | |
| Normalized Basic EPS | -4.62% | -18.51% | -27.69% | -- | |
| EPS Diluted | -4.29% | -19.15% | -27.57% | -39.69% | |
| Normalized Diluted EPS | -4.62% | -18.51% | -27.69% | -- | |
| Average Basic Shares Outstanding | 22.85% | 15.15% | 0.82% | 0.83% | |
| Average Diluted Shares Outstanding | 22.85% | 15.15% | 0.82% | 0.83% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |